Transitional cell carcinoma primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Transitional cell carcinoma}} | {{Transitional cell carcinoma}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
[[Primary prevention]] strategies of bladder cancer include cease smoking, avoid aristolochic acids, and avoid exposure to industrial chemicals and [[arsenic]]. | |||
==Primary Prevention== | ==Primary Prevention== | ||
* Cessation of smoking | |||
* Avoid exposure to industrial chemicals | |||
* Avoid exposure to [[arsenic]] | |||
* Avoid aristolochic acids | |||
==References== | ==References== | ||
Revision as of 14:37, 24 February 2016
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma primary prevention On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma primary prevention |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Primary prevention strategies of bladder cancer include cease smoking, avoid aristolochic acids, and avoid exposure to industrial chemicals and arsenic.
Primary Prevention
- Cessation of smoking
- Avoid exposure to industrial chemicals
- Avoid exposure to arsenic
- Avoid aristolochic acids